-
2
-
-
0030978265
-
Reversibility of insulin resistance in obese diabetic patients: Role of plasma lipids
-
Mingrone G, DeGaetano A, Greco AV et al. Reversibility of insulin resistance in obese diabetic patients: Role of plasma lipids. Diabetologia 1997; 40: 599-605.
-
(1997)
Diabetologia
, vol.40
, pp. 599-605
-
-
Mingrone, G.1
DeGaetano, A.2
Greco, A.V.3
-
3
-
-
0344609217
-
Causes of weight gain during insulin therapy with and without metformin in patients with type II diabetes mellitus
-
Makimattila S, Nikkila K, Yki-Jarvinen H. Causes of weight gain during insulin therapy with and without metformin in patients with type II diabetes mellitus. Diabetologia 1999; 42: 406-412.
-
(1999)
Diabetologia
, vol.42
, pp. 406-412
-
-
Makimattila, S.1
Nikkila, K.2
Yki-Jarvinen, H.3
-
4
-
-
0034819464
-
Combination therapies with insulin in type 2 diabetes
-
Yki-Yärvinen H. Combination therapies with insulin in type 2 diabetes. Diabetes Care 2001; 24: 758-767.
-
(2001)
Diabetes Care
, vol.24
, pp. 758-767
-
-
Yki-Yärvinen, H.1
-
5
-
-
0032511583
-
Intensive blood glucose control with Sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
-
UK Prospective Diabetes Study Group
-
UK Prospective Diabetes Study Group. Intensive blood glucose control with Sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
-
(1998)
Lancet
, vol.352
, pp. 837-853
-
-
-
6
-
-
0023832956
-
Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin dependent diabetes mellitus
-
Campbell PJ, Mandarino LJ, Gerich JE. Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin dependent diabetes mellitus. Metabolism 1988; 37: 15-21.
-
(1988)
Metabolism
, vol.37
, pp. 15-21
-
-
Campbell, P.J.1
Mandarino, L.J.2
Gerich, J.E.3
-
7
-
-
0032700663
-
Measurement of insulin resistance in vivo
-
Del Prato S. Measurement of insulin resistance in vivo. Drugs 1999; 58 (Suppl. 1): 75-82.
-
(1999)
Drugs
, vol.58
, Issue.SUPPL. 1
, pp. 75-82
-
-
Del Prato, S.1
-
8
-
-
0029092489
-
Prevalence and correlates of obesity in insulin dependent diabetic patients
-
Bagnetti F, Macellaro P, Novelli D, Meschi P, Coralli F, Chiomello G. Prevalence and correlates of obesity in insulin dependent diabetic patients. Arch Dis Child 1995; 73: 239-242.
-
(1995)
Arch Dis Child
, vol.73
, pp. 239-242
-
-
Bagnetti, F.1
Macellaro, P.2
Novelli, D.3
Meschi, P.4
Coralli, F.5
Chiomello, G.6
-
9
-
-
0042689028
-
Combination of insulin and metformin in the treatment of type 2 diabetes
-
Wuffele MG, Kooy A, Bets D et al. Combination of insulin and metformin in the treatment of type 2 diabetes. Diabetes Care 2002; 25: 2133-2140.
-
(2002)
Diabetes Care
, vol.25
, pp. 2133-2140
-
-
Wuffele, M.G.1
Kooy, A.2
Bets, D.3
-
10
-
-
0035663674
-
Long-term glycaemic improvement after addition of metformin to insulin in insulin-treated obese type 2 diabetes patients
-
Hermann LS, Kalen J, Katzman P et al. Long-term glycaemic improvement after addition of metformin to insulin in insulin-treated obese type 2 diabetes patients. Diabetes Obes Metab 2001; 3: 428-434.
-
(2001)
Diabetes Obes Metab
, vol.3
, pp. 428-434
-
-
Hermann, L.S.1
Kalen, J.2
Katzman, P.3
-
12
-
-
0036137212
-
Insulin-metformin combination therapy in obese patients with type 2 diabetes
-
Jaber LA, Nowak SN, Slaughter RR. Insulin-metformin combination therapy in obese patients with type 2 diabetes. J Clin Pharmacol 2002; 42: 89-94.
-
(2002)
J Clin Pharmacol
, vol.42
, pp. 89-94
-
-
Jaber, L.A.1
Nowak, S.N.2
Slaughter, R.R.3
-
13
-
-
0030868108
-
Modification with postprandial hyperglycemia with insulin Lispro improves glucose control in patients with type 2 diabetes
-
Feinglos MN, Thacker CH, English J et al. Modification with postprandial hyperglycemia with insulin Lispro improves glucose control in patients with type 2 diabetes. Diabetes Care 1997; 20: 1539-1542.
-
(1997)
Diabetes Care
, vol.20
, pp. 1539-1542
-
-
Feinglos, M.N.1
Thacker, C.H.2
English, J.3
-
14
-
-
0029967145
-
Bodyweight change as an adverse effect of drug treatment. Mechanisms and management
-
Pijl H & Meinders AE. Bodyweight change as an adverse effect of drug treatment. Mechanisms and management. Drug Saf 1996; 14: 329-342.
-
(1996)
Drug Saf
, vol.14
, pp. 329-342
-
-
Pijl, H.1
Meinders, A.E.2
-
15
-
-
0033946189
-
Combined metformin and insulin therapy for patients with type 2 diabetes mellitus
-
Ponssen HH, Elte JW, Lehert P, Schouten JP, Bets D. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus. Clin Ther 2000; 22: 709-718.
-
(2000)
Clin Ther
, vol.22
, pp. 709-718
-
-
Ponssen, H.H.1
Elte, J.W.2
Lehert, P.3
Schouten, J.P.4
Bets, D.5
-
16
-
-
0036397483
-
Metformin adjunctive therapy with insulin improves glycemic control in patients with type 1 diabetes mellitus: A pilot study
-
Gomez R, Mokhashi MH, Rao J et al. Metformin adjunctive therapy with insulin improves glycemic control in patients with type 1 diabetes mellitus: A pilot study. J Pediatr Endocrinol Metab 2002; 15: 1147-1151.
-
(2002)
J Pediatr Endocrinol Metab
, vol.15
, pp. 1147-1151
-
-
Gomez, R.1
Mokhashi, M.H.2
Rao, J.3
|